XOMA Co. (NASDAQ:XOMAP – Get Free Report) saw a significant decrease in short interest in the month of January. As of January 15th, there was short interest totaling 1,989 shares, a decrease of 28.8% from the December 31st total of 2,794 shares. Based on an average daily volume of 1,351 shares, the days-to-cover ratio is currently 1.5 days. Based on an average daily volume of 1,351 shares, the days-to-cover ratio is currently 1.5 days.
XOMA Trading Up 0.6%
Shares of NASDAQ XOMAP opened at $26.15 on Monday. The business’s 50 day moving average is $26.61 and its 200-day moving average is $26.35. XOMA has a 1-year low of $24.96 and a 1-year high of $30.00.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Featured Stories
- Five stocks we like better than XOMA
- Trump just signed it
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- This is the Exact Moment the AI Boom Will End
- GOLD ALERT
- Trump’s Final Shocking Act Begins February 24
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
